Use of consciousness-enhancing medications in the traumatic brain injury patient

Justin R. Davanzo, Shelly Timmons

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

After traumatic brain injury (TBI), patients often experience an altered level of consciousness for some period of time, and deeply altered levels of consciousness may be classified as comatose or vegetative states. Some patients do not fit either of these categories, due to some level of preservation of self-awareness, and are defined as being in a minimally conscious state; patients may progress to this state from coma or vegetative state after a TBI. Understanding the criteria for each of these altered states is important for prognostication purposes. While a large proportion of patients with prolonged coma after a TBI will “awaken” within 1 year, many researchers have focused on utilization of pharmaceutical agents to hasten recovery of consciousness due to the propensity for complications and other deleterious issues associated with prolonged coma. However, as with all medications, the medications used have a side-effect profile that could certainly play a harmful role in recovery. In addition, limited data are available to suggest that these medications actually do aid TBI patients in their recovery. The goal of this chapter is to discuss the available evidence for conscious-enhancing medications for this use.

Original languageEnglish (US)
Title of host publicationControversies in Severe Traumatic Brain Injury Management
PublisherSpringer International Publishing
Pages179-190
Number of pages12
ISBN (Electronic)9783319894775
ISBN (Print)9783319894768
DOIs
StatePublished - Jan 1 2018

Fingerprint

Consciousness
Coma
Persistent Vegetative State
Consciousness Disorders
Research Personnel
Traumatic Brain Injury
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Davanzo, J. R., & Timmons, S. (2018). Use of consciousness-enhancing medications in the traumatic brain injury patient. In Controversies in Severe Traumatic Brain Injury Management (pp. 179-190). Springer International Publishing. https://doi.org/10.1007/978-3-319-89477-5_15
Davanzo, Justin R. ; Timmons, Shelly. / Use of consciousness-enhancing medications in the traumatic brain injury patient. Controversies in Severe Traumatic Brain Injury Management. Springer International Publishing, 2018. pp. 179-190
@inbook{7f6c09986e184dcabc8ed751af98d921,
title = "Use of consciousness-enhancing medications in the traumatic brain injury patient",
abstract = "After traumatic brain injury (TBI), patients often experience an altered level of consciousness for some period of time, and deeply altered levels of consciousness may be classified as comatose or vegetative states. Some patients do not fit either of these categories, due to some level of preservation of self-awareness, and are defined as being in a minimally conscious state; patients may progress to this state from coma or vegetative state after a TBI. Understanding the criteria for each of these altered states is important for prognostication purposes. While a large proportion of patients with prolonged coma after a TBI will “awaken” within 1 year, many researchers have focused on utilization of pharmaceutical agents to hasten recovery of consciousness due to the propensity for complications and other deleterious issues associated with prolonged coma. However, as with all medications, the medications used have a side-effect profile that could certainly play a harmful role in recovery. In addition, limited data are available to suggest that these medications actually do aid TBI patients in their recovery. The goal of this chapter is to discuss the available evidence for conscious-enhancing medications for this use.",
author = "Davanzo, {Justin R.} and Shelly Timmons",
year = "2018",
month = "1",
day = "1",
doi = "10.1007/978-3-319-89477-5_15",
language = "English (US)",
isbn = "9783319894768",
pages = "179--190",
booktitle = "Controversies in Severe Traumatic Brain Injury Management",
publisher = "Springer International Publishing",

}

Davanzo, JR & Timmons, S 2018, Use of consciousness-enhancing medications in the traumatic brain injury patient. in Controversies in Severe Traumatic Brain Injury Management. Springer International Publishing, pp. 179-190. https://doi.org/10.1007/978-3-319-89477-5_15

Use of consciousness-enhancing medications in the traumatic brain injury patient. / Davanzo, Justin R.; Timmons, Shelly.

Controversies in Severe Traumatic Brain Injury Management. Springer International Publishing, 2018. p. 179-190.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Use of consciousness-enhancing medications in the traumatic brain injury patient

AU - Davanzo, Justin R.

AU - Timmons, Shelly

PY - 2018/1/1

Y1 - 2018/1/1

N2 - After traumatic brain injury (TBI), patients often experience an altered level of consciousness for some period of time, and deeply altered levels of consciousness may be classified as comatose or vegetative states. Some patients do not fit either of these categories, due to some level of preservation of self-awareness, and are defined as being in a minimally conscious state; patients may progress to this state from coma or vegetative state after a TBI. Understanding the criteria for each of these altered states is important for prognostication purposes. While a large proportion of patients with prolonged coma after a TBI will “awaken” within 1 year, many researchers have focused on utilization of pharmaceutical agents to hasten recovery of consciousness due to the propensity for complications and other deleterious issues associated with prolonged coma. However, as with all medications, the medications used have a side-effect profile that could certainly play a harmful role in recovery. In addition, limited data are available to suggest that these medications actually do aid TBI patients in their recovery. The goal of this chapter is to discuss the available evidence for conscious-enhancing medications for this use.

AB - After traumatic brain injury (TBI), patients often experience an altered level of consciousness for some period of time, and deeply altered levels of consciousness may be classified as comatose or vegetative states. Some patients do not fit either of these categories, due to some level of preservation of self-awareness, and are defined as being in a minimally conscious state; patients may progress to this state from coma or vegetative state after a TBI. Understanding the criteria for each of these altered states is important for prognostication purposes. While a large proportion of patients with prolonged coma after a TBI will “awaken” within 1 year, many researchers have focused on utilization of pharmaceutical agents to hasten recovery of consciousness due to the propensity for complications and other deleterious issues associated with prolonged coma. However, as with all medications, the medications used have a side-effect profile that could certainly play a harmful role in recovery. In addition, limited data are available to suggest that these medications actually do aid TBI patients in their recovery. The goal of this chapter is to discuss the available evidence for conscious-enhancing medications for this use.

UR - http://www.scopus.com/inward/record.url?scp=85064534803&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064534803&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-89477-5_15

DO - 10.1007/978-3-319-89477-5_15

M3 - Chapter

AN - SCOPUS:85064534803

SN - 9783319894768

SP - 179

EP - 190

BT - Controversies in Severe Traumatic Brain Injury Management

PB - Springer International Publishing

ER -

Davanzo JR, Timmons S. Use of consciousness-enhancing medications in the traumatic brain injury patient. In Controversies in Severe Traumatic Brain Injury Management. Springer International Publishing. 2018. p. 179-190 https://doi.org/10.1007/978-3-319-89477-5_15